Trofinetide Granted Rare Pediatric Disease Designation for the Treatment of Rett Syndrome
ACADIA Pharmaceuticals, working with Neuren Pharmaceuticals, has recently been granted the Rare Pediatric Disease designation from the FDA for their therapy Trofinetide. This drug is intended for the treatment of…